Emma R. Thompson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emma R. Thompson has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Aatin Dhanda
Department of Otolaryngology‐Head and Neck Surgery Rutgers New Jersey Medical School Newark New Jersey USA
2 shared publicationsAvi Shah
Division of Infectious Disease Center for Data Science, Rutgers New Jersey Medical School Newark New Jersey USA
2 shared publicationsAvleen Mudhar
Department of Oral Biology Rutgers Health School of Dental Medicine Newark New Jersey USA
2 shared publicationsCarla Cugini
Department of Oral Biology Rutgers Health School of Dental Medicine Newark New Jersey USA
2 shared publicationsJamie Bono
Department of Medicine Rowan‐Virtua School of Osteopathic Medicine Stratford New Jersey USA
2 shared publicationsKenneth Yan
Department of Otolaryngology‐Head and Neck Surgery Rutgers New Jersey Medical School Newark New Jersey USA
2 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in The Laryngoscope
Laryngeal Cancer Microbiome Study Reveals Parvimonas and Campylobacter as Potential Therapy Targets
Objective: Laryngeal cancer accounts for 40% of head and neck malignancies and 1% of all cancer‐related deaths worldwide. We evaluated the laryngeal cancer microbiome to identify cancer‐specific genera as potential treatment targets. Methods: A prospective study was conducted using 57 laryngeal mucosal samples from 24 treatment‐naive laryngeal cancer patients and 33 patients who were undergoing otolaryngological surgery unrelated to oral or laryngeal diseases (01/2023–09/2025). DNA was extracted and amplified in triplicate, targeting the V3/V4 region of the 16S rRNA gene, followed by paired‐end 2 × 300 bp sequencing on the Illumina NextSeq 2000. Amplicon sequence variants were identified via DADA2 and assigned to genera using a naive Bayes classifier. Two samples with zero classified read pairs were excluded. Results: Most patients were male (87.5% cancer, 66.7% controls) and smokers (83.3% cancer, 54.5% controls). Cancer patients' core laryngeal microbiomes uniquely contained Parvimonas (3.67%; 95% CI: 0.70%–6.64%), and Campylobacter (1.12%; 95% CI: 0.60%–1.63%), while control patients' uniquely contained Corynebacterium (2.97%; 95% CI: 0.00%–7.67%) and Alloprevotella (1.34%; 95% CI: 0.64%–2.04%). Cancer samples were significantly enriched in 19 genera, notably Peptococcus (2.93, q = 0.0003), Campylobacter (1.68, q = 0.009), and Parvimonas (2.02, q = 0.03), compared to controls. Conclusions: Laryngeal cancer patients' samples displayed microbial dysbiosis, with enrichment of microbes present in gastrointestinal cancers, cervical cancer, and inflammatory states; they also exhibited loss of immunoprotective taxa. These findings support that microbiome profiling can distinguish malignant mucosa and guide future studies targeting genera increased in cancer, including Parvimonas and Campylobacter . Level of Evidence: 3.
- 5 November 2026
- Published by Wiley in The Laryngoscope
Open AccessLaryngeal Cancer Microbiome Study Reveals Parvimonas and Campylobacter as Potential Therapy Targets
Objective: Laryngeal cancer accounts for 40% of head and neck malignancies and 1% of all cancer‐related deaths worldwide. We evaluated the laryngeal cancer microbiome to identify cancer‐specific genera as potential treatment targets. Methods: A prospective study was conducted using 57 laryngeal mucosal samples from 24 treatment‐naive laryngeal cancer patients and 33 patients who were undergoing otolaryngological surgery unrelated to oral or laryngeal diseases (01/2023–09/2025). DNA was extracted and amplified in triplicate, targeting the V3/V4 region of the 16S rRNA gene, followed by paired‐end 2 × 300 bp sequencing on the Illumina NextSeq 2000. Amplicon sequence variants were identified via DADA2 and assigned to genera using a naive Bayes classifier. Two samples with zero classified read pairs were excluded. Results: Most patients were male (87.5% cancer, 66.7% controls) and smokers (83.3% cancer, 54.5% controls). Cancer patients' core laryngeal microbiomes uniquely contained Parvimonas (3.67%; 95% CI: 0.70%–6.64%), and Campylobacter (1.12%; 95% CI: 0.60%–1.63%), while control patients' uniquely contained Corynebacterium (2.97%; 95% CI: 0.00%–7.67%) and Alloprevotella (1.34%; 95% CI: 0.64%–2.04%). Cancer samples were significantly enriched in 19 genera, notably Peptococcus (2.93, q = 0.0003), Campylobacter (1.68, q = 0.009), and Parvimonas (2.02, q = 0.03), compared to controls. Conclusions: Laryngeal cancer patients' samples displayed microbial dysbiosis, with enrichment of microbes present in gastrointestinal cancers, cervical cancer, and inflammatory states; they also exhibited loss of immunoprotective taxa. These findings support that microbiome profiling can distinguish malignant mucosa and guide future studies targeting genera increased in cancer, including Parvimonas and Campylobacter . Level of Evidence: 3.
- Open Access
- 8 January 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (3) , 733-740
Facial Nerve Palsy in Malignant Otitis Externa Hospitalizations: Outcomes and Risk Factors
Objective: To provide a description of the occurrence of facial nerve palsy in hospitalizations for malignant otitis externa and to compare the demographic characteristics, hospital traits, comorbidities, and outcomes between patients with and without palsy. Study Design: Retrospective cross‐sectional database study. Setting: 2016 to 2022 National Inpatient Sample (NIS). Methods: Hospitalizations for malignant otitis externa were identified using ICD‐10 diagnosis codes, and facial nerve palsy was identified using secondary diagnosis codes. Weighted discharge level rates of facial nerve palsy were calculated, and demographics, comorbidities, and outcomes were compared between patients with and without facial nerve palsy. Results: 695 (12.4%) of 5,585 MOE inpatient stays involved facial nerve palsy. Stays involving palsy were significantly more likely to occur in older patients (71.16 ± 13.4 years vs 56.07 ± 21.1 years, P < .001), in men (70.7% vs 55.6%, P < .001), have a higher number of diagnoses (17.51 vs 13.2, P < .001) and chronic conditions (7.91 vs 7.01, P = .001) than stays without palsy. Diabetes with chronic complications, complicated and uncomplicated hypertension, and peripheral vascular disease were all significantly more common within the palsy group. Hospitalizations with a palsy diagnosis were associated with longer hospital stays, (7.80 ± 7.5 days vs 5.21 ± 6.8 days, P < .001), with smaller proportions of stays resulting in routine discharge. Conclusion: One in eight US inpatient stays for MOE involved facial nerve palsy, which was associated with older age, advanced comorbidities, longer hospitalizations, and increased care needs following discharge. These findings support the association of facial nerve palsy with heightened comorbidity burden.
- 8 January 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (3) , 733-740
Open AccessFacial Nerve Palsy in Malignant Otitis Externa Hospitalizations: Outcomes and Risk Factors
Objective: To provide a description of the occurrence of facial nerve palsy in hospitalizations for malignant otitis externa and to compare the demographic characteristics, hospital traits, comorbidities, and outcomes between patients with and without palsy. Study Design: Retrospective cross‐sectional database study. Setting: 2016 to 2022 National Inpatient Sample (NIS). Methods: Hospitalizations for malignant otitis externa were identified using ICD‐10 diagnosis codes, and facial nerve palsy was identified using secondary diagnosis codes. Weighted discharge level rates of facial nerve palsy were calculated, and demographics, comorbidities, and outcomes were compared between patients with and without facial nerve palsy. Results: 695 (12.4%) of 5,585 MOE inpatient stays involved facial nerve palsy. Stays involving palsy were significantly more likely to occur in older patients (71.16 ± 13.4 years vs 56.07 ± 21.1 years, P < .001), in men (70.7% vs 55.6%, P < .001), have a higher number of diagnoses (17.51 vs 13.2, P < .001) and chronic conditions (7.91 vs 7.01, P = .001) than stays without palsy. Diabetes with chronic complications, complicated and uncomplicated hypertension, and peripheral vascular disease were all significantly more common within the palsy group. Hospitalizations with a palsy diagnosis were associated with longer hospital stays, (7.80 ± 7.5 days vs 5.21 ± 6.8 days, P < .001), with smaller proportions of stays resulting in routine discharge. Conclusion: One in eight US inpatient stays for MOE involved facial nerve palsy, which was associated with older age, advanced comorbidities, longer hospitalizations, and increased care needs following discharge. These findings support the association of facial nerve palsy with heightened comorbidity burden.
- Open Access
- 17 September 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (5)
Nutritional Status and Outcomes Following Open Laryngeal Surgery for Laryngeal Cancer: A NSQIP Database Study
Objectives: Malnutrition and weight loss in patients with laryngeal cancer impair immune function and wound healing. Understanding how underweight status impacts outcomes is crucial to improving care. Accordingly, we evaluated perioperative outcomes of patients undergoing laryngectomy for laryngeal cancer, with a secondary focus on patients with recent unintentional weight loss. Methods: This retrospective cohort study used the American College of Surgeons National Surgical Quality Improvement Program database. CPT codes were used to identify patients undergoing open total or partial laryngectomies for cancer. Only those with underweight (< 18.5) or normal weight (18.5–29.9) BMIs were included. A subgroup analysis assessed patients with recent unintentional weight loss. Univariate and multivariate analyses were performed, with significance set at p < 0.05. Results: 2012 patients were analyzed: 276 underweight (79 female, 197 male) and 1736 normal weight (306 female, 1430 male). Age distribution among underweight patients was 2.5% (ages 20–44), 76.1% (ages 45–69), and 21.4% (ages 70–90), compared to 2.9%, 66.7%, and 30.1%, respectively, in normal‐weight patients. Underweight patients were more likely to experience medical complications ( p < 0.001), longer hospital stays ( p < 0.001), wound disruptions ( p = 0.002), and to have greater transfusion requirements ( p < 0.001). In those with recent, unintentional weight loss, underweight individuals were at increased risk of experiencing medical complications ( p = 0.046) and requiring a transfusion ( p < 0.001), but were not more likely to experience wound disruptions ( p = 0.119) or experience increased lengths of stay ( p = 0.225). Conclusion: Underweight status and recent weight loss are associated with heightened risks of perioperative medical complications and transfusions. Preoperative optimization may enhance surgical recovery and outcomes. Level of Evidence: Level 3.
- 17 September 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (5)
Open AccessNutritional Status and Outcomes Following Open Laryngeal Surgery for Laryngeal Cancer: A NSQIP Database Study
Objectives: Malnutrition and weight loss in patients with laryngeal cancer impair immune function and wound healing. Understanding how underweight status impacts outcomes is crucial to improving care. Accordingly, we evaluated perioperative outcomes of patients undergoing laryngectomy for laryngeal cancer, with a secondary focus on patients with recent unintentional weight loss. Methods: This retrospective cohort study used the American College of Surgeons National Surgical Quality Improvement Program database. CPT codes were used to identify patients undergoing open total or partial laryngectomies for cancer. Only those with underweight (< 18.5) or normal weight (18.5–29.9) BMIs were included. A subgroup analysis assessed patients with recent unintentional weight loss. Univariate and multivariate analyses were performed, with significance set at p < 0.05. Results: 2012 patients were analyzed: 276 underweight (79 female, 197 male) and 1736 normal weight (306 female, 1430 male). Age distribution among underweight patients was 2.5% (ages 20–44), 76.1% (ages 45–69), and 21.4% (ages 70–90), compared to 2.9%, 66.7%, and 30.1%, respectively, in normal‐weight patients. Underweight patients were more likely to experience medical complications ( p < 0.001), longer hospital stays ( p < 0.001), wound disruptions ( p = 0.002), and to have greater transfusion requirements ( p < 0.001). In those with recent, unintentional weight loss, underweight individuals were at increased risk of experiencing medical complications ( p = 0.046) and requiring a transfusion ( p < 0.001), but were not more likely to experience wound disruptions ( p = 0.119) or experience increased lengths of stay ( p = 0.225). Conclusion: Underweight status and recent weight loss are associated with heightened risks of perioperative medical complications and transfusions. Preoperative optimization may enhance surgical recovery and outcomes. Level of Evidence: Level 3.
- 14 August 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 281-290
Early Insights Into the Healthy Laryngeal Microbiome: A Pilot Study Evaluating Salivary and Oropharyngeal Sampling as Proxies
Objectives: The microbiome plays a critical role in health and disease. While the oral cavity microbiome is well‐characterized, the healthy laryngeal microbiome remains underexplored despite its unique immunological role. Laryngeal sampling is more invasive, time‐consuming, and costly than salivary and oropharyngeal sampling. Understanding microbial differences between sites can help optimize sampling strategies. Methods: Nineteen individuals undergoing otolaryngologic surgery for non‐oral or laryngeal disease were included. Matched saliva, oropharyngeal swabs, and laryngeal swabs were collected. DNA was extracted, and the V3/V4 region of the 16S rRNA gene was amplified and sequenced using Illumina NextSeq 2000. Amplicon sequence variants were identified via DADA2, and taxa were classified using a hybrid alignment/naïve Bayes approach. Microbial diversity was assessed using alpha and beta diversity measures. Results: Among 19 participants (31.6% female, mean age 61), most identified as Spanish, Hispanic, or Latino (36.8%). No significant differences were found in taxa diversity between the saliva, oropharynx, and larynx. Core microbiomes shared 13 taxa, with unique taxa in saliva and larynx. While unadjusted comparisons showed that some taxa were differentially abundant between the saliva and the larynx, these differences did not remain significant after correction for multiple comparisons using false discovery rate. Microbiome composition did not predict sample site. Conclusion: While both salivary and oropharyngeal samples showed similar taxonomic diversity to the larynx, the oropharynx is a superior surrogate, sharing more core taxa, and lacking unique core taxa of its own. The oropharynx could represent a cost‐effective alternative for microbiome diagnostics, enhancing patient comfort and clinical feasibility without compromising insights. Level of Evidence: Level 3—small prospective cohort study.
- 14 August 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 281-290
Early Insights Into the Healthy Laryngeal Microbiome: A Pilot Study Evaluating Salivary and Oropharyngeal Sampling as Proxies
Objectives: The microbiome plays a critical role in health and disease. While the oral cavity microbiome is well‐characterized, the healthy laryngeal microbiome remains underexplored despite its unique immunological role. Laryngeal sampling is more invasive, time‐consuming, and costly than salivary and oropharyngeal sampling. Understanding microbial differences between sites can help optimize sampling strategies. Methods: Nineteen individuals undergoing otolaryngologic surgery for non‐oral or laryngeal disease were included. Matched saliva, oropharyngeal swabs, and laryngeal swabs were collected. DNA was extracted, and the V3/V4 region of the 16S rRNA gene was amplified and sequenced using Illumina NextSeq 2000. Amplicon sequence variants were identified via DADA2, and taxa were classified using a hybrid alignment/naïve Bayes approach. Microbial diversity was assessed using alpha and beta diversity measures. Results: Among 19 participants (31.6% female, mean age 61), most identified as Spanish, Hispanic, or Latino (36.8%). No significant differences were found in taxa diversity between the saliva, oropharynx, and larynx. Core microbiomes shared 13 taxa, with unique taxa in saliva and larynx. While unadjusted comparisons showed that some taxa were differentially abundant between the saliva and the larynx, these differences did not remain significant after correction for multiple comparisons using false discovery rate. Microbiome composition did not predict sample site. Conclusion: While both salivary and oropharyngeal samples showed similar taxonomic diversity to the larynx, the oropharynx is a superior surrogate, sharing more core taxa, and lacking unique core taxa of its own. The oropharynx could represent a cost‐effective alternative for microbiome diagnostics, enhancing patient comfort and clinical feasibility without compromising insights. Level of Evidence: Level 3—small prospective cohort study.